Trial reportMolecular vision2010
Smell perception in normal tension glaucoma patients.
Trial report in Molecular vision, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Olfactory Dysfunction and Glaucoma.Biomedicines · 2024Review
- [Glaucoma Patient with Suspected Flammer Syndrome: Diagnostic Procedures and Therapeutic Implications].Klinische Monatsblatter fur Augenheilkunde · 2024Review
- Retinal venous pressure measurements in patients with Flammer syndrome and metabolic syndrome.The EPMA journal · 2017Article
- Relationship between normal tension glaucoma and Flammer syndrome.The EPMA journal · 2017Article
- The discovery of the Flammer syndrome: a historical and personal perspective.The EPMA journal · 2017Review
- The effect of nifedipine on retinal venous pressure of glaucoma patients with the Flammer-Syndrome.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2015Article
- The effect of flammer-syndrome on retinal venous pressure.BMC ophthalmology · 2014Article
- The primary vascular dysregulation syndrome: implications for eye diseases.The EPMA journal · 2013Article
- OLAF: standardization of international olfactory tests.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of this study was to quantify the ability to identify odors in normal tension glaucoma (NTG) patients and healthy subjects with and without a primary vascular dysregulation (PVD).
methodsBoth self-assessment of smell perception and evaluation of odor identification by means of the 12-item odor identification test ("Sniffin' Sticks") were performed in the following groups of subjects: 1) 18 NTG patients with PVD (G+), 2) 18 NTG patients without PVD (G-), 3) 18 healthy subjects with PVD (H(+)) and 4) 18 healthy subjects without PVD (H-). The subjects self-assessment of smell perception was evaluated before the Sniffin' Sticks test by asking them to judge their ability to identify odors as either "average," "better than average," or "worse than average."
resultsSubjects with a PVD (G+ and H(+)) can identify odors significantly better than those without a PVD (G- and H-; in a score scale of 1-12 the score point difference=2.64, 95% CI=1.88-3.40, p<0.001). No significant differences in odor identification was found between NTG (groups G+ and G-) and healthy subjects (groups H(+) and H-; score point difference=-0.14, 95% CI=-0.9-0.62, p=0.72).
conclusionsSubjects with a PVD can identify odors significantly better than those without a PVD.
Indexed as
Identifiers
20352025PMC2845666What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.